Concord Medical Services Holdings Limited (CCM)
| Market Cap | 21.71M -41.2% |
| Revenue (ttm) | 65.84M +19.9% |
| Net Income | -13.27M |
| EPS | -3.05 |
| Shares Out | 4.34M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,894 |
| Open | 5.12 |
| Previous Close | 5.06 |
| Day's Range | 4.80 - 6.04 |
| 52-Week Range | 3.18 - 10.77 |
| Beta | -1.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 29, 2026 |
About CCM
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the com... [Read more]
Financial Performance
In 2025, CCM's revenue was 460.51 million, an increase of 19.94% compared to the previous year's 383.96 million. Losses were -92.81 million, -69.89% less than in 2024.
Financial numbers in CNY Financial StatementsNews
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
BEIJING, April 29, 2026 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu...
Concord Medical Schedules 2025 Annual Meeting of Shareholders
BEIJING , Dec. 2, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, educ...
Concord Medical trading resumes
11:52 EDT Concord Medical (CCM) trading resumes
Concord Medical trading halted, volatility trading pause
11:46 EDT Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical Reports Financial Results for the First Half of 2025
BEIJING , Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, ed...
Concord Medical trading resumes
14:49 EDT Concord Medical (CCM) trading resumes
Concord Medical trading halted, volatility trading pause
14:44 EDT Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical trading resumes
09:42 EDT Concord Medical (CCM) trading resumes
Concord Medical trading halted, volatility trading pause
09:36 EDT Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical trading resumes
09:35 EDT Concord Medical (CCM) trading resumes
Concord Medical trading halted, volatility trading pause
09:30 EDT Concord Medical (CCM) trading halted, volatility trading pause
Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma
BEIJING , July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidia...
Concord Healthcare Announces Official Release of the Proton Therapy Large Model
BEIJING , May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiar...
Concord Medical trading halted, volatility trading pause
14:01 EDT Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
BEIJING , April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, ed...
Concord Medical Announces Result of 2024 Annual General Meeting
BEIJING , Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, educ...
Concord Medical trading halted, volatility trading pause
13:14 EST Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical trading halted, volatility trading pause
13:46 EST Concord Medical (CCM) trading halted, volatility trading pause
Concord Medical: Application for proton therapy equipment registration approved
Concord Medical (CCM) Services announced that the National Medical Products Administration of the People’s Republic of China has granted approval to the application for the Registration Certificate fo...
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING , Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, educ...
Concord Medical Schedules 2024 Annual Meeting of Shareholders
BEIJING , Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu...


